Premarket Review Approval For COVID-19 Test Is US FDA's First For OTC Respiratory Diagnostic
Executive Summary
FDA’s first premarket approval of OTC test for any respiratory illness went to first firm to receive an EUA for at-home molecular COVID-19 test, Cue Health, which had received $481m from agency to spur its diagnostics development.